{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:50:06Z","timestamp":1791348606747,"version":"4.3.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xphs.2026.104510","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:39:07Z","timestamp":1789799947000},"page":"104510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluorescence-based assay for evaluating SLC49A4 function: Identification of acriflavine as a probe substrate"],"prefix":"10.1016","volume":"115","author":[{"given":"Ryosuke","family":"Matsubara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3863-5063","authenticated-orcid":false,"given":"Tomoya","family":"Yasujima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-6694","authenticated-orcid":false,"given":"Hiroaki","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104510_bib0001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol Pathol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104510_bib0002","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/hsz-2019-0270","article-title":"Emerging mechanisms of drug-induced phospholipidosis","volume":"401","author":"Breiden","year":"2019","journal-title":"Biol Chem"},{"issue":"4","key":"10.1016\/j.xphs.2026.104510_bib0003","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1124\/dmd.112.050054","article-title":"Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells)","volume":"41","author":"Kazmi","year":"2013","journal-title":"Drug Metab Disposit Biol Fate Chem"},{"issue":"18","key":"10.1016\/j.xphs.2026.104510_bib0004","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Commentary. Lysosomotropic agents","volume":"23","author":"de Duve","year":"1974","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104510_bib0005","first-page":"31","article-title":"Influence of lysosomal sequestration on multidrug resistance in cancer cells","volume":"2","author":"Halaby","year":"2019","journal-title":"Cancer Drug Resist"},{"issue":"20","key":"10.1016\/j.xphs.2026.104510_bib0006","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1038\/s41388-019-0695-8","article-title":"Lysosomal trapping of palbociclib and its functional implications","volume":"38","author":"Llanos","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.xphs.2026.104510_bib0007","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/mp200641e","article-title":"Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction","volume":"9","author":"Funk","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2026.104510_bib0008","article-title":"New insights into the intracellular distribution pattern of cationic amphiphilic drugs","volume":"7","author":"Vater","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.xphs.2026.104510_bib0009","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1248\/bpb.b16-00140","article-title":"Lysosomal trapping is present in retinal capillary endothelial cells: insight into its influence on cationic drug transport at the inner blood-retinal barrier","volume":"39","author":"Kubo","year":"2016","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"10.1016\/j.xphs.2026.104510_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11095-018-2384-7","article-title":"Blood-to-retina transport of fluorescence-labeled verapamil at the blood-retinal barrier","volume":"35","author":"Kubo","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104510_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2023.100510","article-title":"Characterization of LysoTracker Red uptake by in vitro model cells of the outer blood-retinal barrier: implication of lysosomal trapping with cytoplasmic vacuolation and cytotoxicity","volume":"51","author":"Tega","year":"2023","journal-title":"Drug Metab Pharmacokinet"},{"issue":"12","key":"10.1016\/j.xphs.2026.104510_bib0012","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1600-0854.2007.00643.x","article-title":"Integral and associated lysosomal membrane proteins","volume":"8","author":"Schroder","year":"2007","journal-title":"Traffic"},{"issue":"1","key":"10.1016\/j.xphs.2026.104510_bib0013","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20110166","article-title":"Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L","volume":"439","author":"Savalas","year":"2011","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.xphs.2026.104510_bib0014","first-page":"81","article-title":"Potentiometric and conductimetric studies of chemical equilibria for pyridoxine hydrochloride in aqueous solutions: simple experimental determination of pka values and analytical applications to pharmaceutical analysis","volume":"35","author":"TDAD","year":"2010","journal-title":"Ecl\u00e9t Qu\u00edm J"},{"issue":"2","key":"10.1016\/j.xphs.2026.104510_bib0015","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201629","article-title":"Disrupted in renal carcinoma 2 (DIRC2\/SLC49A4) is an H(+)-driven lysosomal pyridoxine exporter","volume":"6","author":"Akino","year":"2023","journal-title":"Life Sci Allian"},{"key":"10.1016\/j.xphs.2026.104510_bib0016","doi-asserted-by":"crossref","unstructured":"Akino S., Yasujima T., Shibutani R., Yamashiro T., Yuasa H. Involvement of proton-coupled SLC49A4-mediated transport in the export of lysosomally trapped pyrilamine. Drug Metab Disposit Biol Fate Chem 2023;52(1). https:\/\/doi.org\/10.1124\/dmd.123.001354.","DOI":"10.1124\/dmd.123.001354"},{"issue":"1","key":"10.1016\/j.xphs.2026.104510_bib0017","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s004240000283","article-title":"NBD-TMA: a novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubules","volume":"440","author":"Bednarczyk","year":"2000","journal-title":"Pflugers Arch"},{"issue":"9","key":"10.1016\/j.xphs.2026.104510_bib0018","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1002\/jps.22548","article-title":"Characterization of human OCT1-mediated transport of DAPI as a fluorescent probe substrate","volume":"100","author":"Yasujima","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104510_bib0019","doi-asserted-by":"crossref","unstructured":"Yasujima T., Ohta K.Y., Inoue K., Ishimaru M., Yuasa H. Evaluation of 4\u2032,6-diamidino-2-phenylindole as a fluorescent probe substrate for rapid assays of the functionality of human multidrug and toxin extrusion proteins. Drug Metab Disposit Biol Fate Chem 2010;38(4):715\u2013721. https:\/\/doi.org\/10.1124\/dmd.109.030221.","DOI":"10.1124\/dmd.109.030221"},{"issue":"1","key":"10.1016\/j.xphs.2026.104510_bib0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2010.06.012","article-title":"Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3","volume":"405","author":"Bednarczyk","year":"2010","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.xphs.2026.104510_bib0021","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/s41598-018-20815-1","article-title":"Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of organic anion-transporting polypeptides, OATP1B1\/1B3 and 2B1","volume":"8","author":"Patik","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.xphs.2026.104510_bib0022","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100648R","article-title":"8-acetoxy-trisulfopyrene as the first activatable fluorogenic probe for add-and-read assessment of organic anion-transporting polypeptides, OATP1B1, OATP1B3, and OATP2B1","volume":"35","author":"Ungvari","year":"2021","journal-title":"FASEB J"},{"issue":"18","key":"10.1016\/j.xphs.2026.104510_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810599","article-title":"Selective fluorescent probes for high-throughput functional diagnostics of the human multidrug transporter P-glycoprotein (ABCB1)","volume":"23","author":"Szabo","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104510_bib0024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics8020012","article-title":"Evaluation of P-glycoprotein inhibitory potential using a rhodamine 123 accumulation assay","volume":"8","author":"Jouan","year":"2016","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.xphs.2026.104510_bib0025","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00280-007-0676-4","article-title":"Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals","volume":"62","author":"Nabekura","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104510_bib0026","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1158\/0008-5472.CAN-03-3298","article-title":"Pheophorbide a is a specific probe for ABCG2 function and inhibition","volume":"64","author":"Robey","year":"2004","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104510_bib0027","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V99.2.507","article-title":"The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors","volume":"99","author":"Scharenberg","year":"2002","journal-title":"Blood"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:54:36Z","timestamp":1791345276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022354926003606"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104510","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorescence-based assay for evaluating SLC49A4 function: Identification of acriflavine as a probe substrate","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104510"}}